hepastem
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 12, 2018 (NCT03884959)
Timeline
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04229901 | Phase 2 | Jan 31, 2020 | Promethera Biosciences |
| NCT03963921 | Phase 1/Phase 2 (Phase 2) | Apr 9, 2019 | Promethera Biosciences |
| NCT03884959 | Phase 2 | Jul 12, 2018 | LIFELIVER, Sungkyunkwan University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Promethera Biosciences | For profit | 2 | 2 | 1 | 2019 |
| LIFELIVER | For profit | 1 | 1 | 1 | 2018 |
| Sungkyunkwan University | Academic/Hospital | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1